In this interview Melissa Finocchio, Director, Product Labeling and Documentation BioMerieux, speaks to Andrea Charles from Pharma IQ about changing trends in product labelling and documentation for medical devices, overcoming barriers to standardisation and BioMerieux's top 3 priorities for 2014 now that the FDA Final Rule on UDIs for medical devices is out.
Pharma IQ: What trends are you witnessing with regards to product labelling and documentation for medic...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More